JENNIFER SMITH: Open Payments
NPI 1669579777 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 8 payments from 4 companies in 2025. Trend: 2023 $353 · 2024 $105 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $124 |
| Novo Nordisk Inc | 4 | $85 |
| Pharmacosmos Therapeutics Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: AREXVY, MONOFERRIC, Wegovy, Ozempic, ICLUSIG.
Industry payments across KY — which companies pay providers there.
